Inactive Ingredient Disclosure Expansion In House User Fee Bill Poised For Changes

Republicans share brand industry worry about disclosure of confidential commercial information, suggesting changes may be possible during the upcoming full committee bill mark-up.

Fred Upton discusses House user fee bill
Rep. Fred Upton, R-MI, debates the inactive ingredient provision in the House user fee reauthorization bill. • Source: Screenshot

More from Generics

More from Biosimilars & Generics